Maverix Medical Expands the Narwhal™ Cryo Portfolio with FDA Clearance of the Narwhal Pro
Second console-free cryoprobe connects directly to shorter bronchoscopes and optimizes probe positioning control MENLO PARK, Calif., Oct. 14, 2026/PRNewswire/ -- Maverix Medical, a company focused on revolutionizing the diagnosis and treatment of lung cancer, has augmented its...
Covered in this story
Call it yourself
No calls on $PARK yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Park Dental Partners →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.